Abstract:BACKGROUND:To investigate the protective efficacy of miR-155 on down regulating NADPH oxidase isoform subunit A1 (NoxA1) gene expression, resulting in inhibition of VSMC migration and over proliferation and thus ameliorating the progression of arterial atherosclerosis in AS mouse model. Therefore, to further explore the regulatory effect of miR-155 on neointima formation in AS and locate potential anti-atherosclerosis target.METHODS:The mouse vascular aorta smooth muscle cell (MOVAS) was cultured and transfected with recombinant Pad2YFG adenovirus fluorescent vector with miR-155 fragment into 4 groups. Western blotting and RT-PCR were performed to identify the expression of NoxA1 under different circumstances. Fluorescence microscope was applied to observe the transfection rate of miR-155 into adenovirus. Twelve-week fatty food induced atherosclerotic ApoE-/- mouse model was established as host to accept miR-155 transfected adenovirus transplantation to observe its effect on VSMC in AS progression. Carotid and thoracic artery were extracted at 1 month after dosing. Distribution of miR-155 was quantified via expression levels of protein and RNA to detect NoxA1, Nox1, p47phox and NADPH expression. Immunohistochemistry, fluorescence imaging and other methods were performed in arteries section to compare the thickness of neointima and assess the severity of AS in each group.RESULTS:Luciferase reporter gene assay showed significant expression of miR-155 in mimic group indicating that miR-155 had target binding effect with NoxA1 gene. Western blotting and RT-PCR results both showed significantly decreased NoxA1 expression in miR-155 mimic group while increased with its inhibitor. The miR-155 distribution was observed varied at 1 month after in control, miR-155 mimic and inhibitor groups. The NoxA1, NADPH, Nox1 and pp47phox protein expression in VSMC was decreased in mimic group vs control and inhibitor groups (P<0.05); no significant difference of NADPH expression was observed in all groups. The NoxA1, Nox1 and p47phox gene expression in VSMC were both found reduced compared with those of control group at week 4 (P<0.05). Immunohistochemistry staining of artery frozen sections figured out that the thickness of neointima of carotid artery in miR-155 mimic group was significantly lower vs control and inhibitor groups (P<0.01) at week 4.CONCLUSIONS:miR-155 played an important role in NoxA1-related signaling pathway. miR-155 transfection into VSMC may have anti-inflammatory regulatory effect on NoxA1 expression in vivo and resulting in amelioration of atherosclerotic lesion in AS mouse model. In summary, miR-155 specifically plays in a negative feedback loop and demonstrates a protective role during atherosclerosis-associated VSMC proliferation and neointima formation through the miR-155-NoxA1-p47phox complex signaling pathway.

Toll-like receptor 3 increase the expression of interferon-β in atherosclerosis

Ablation of Interferon Regulatory Factor 3 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice

Oxhdl_3 and Oxldl Induce the Expression of IL-1β,IL-6,HLA-DR,and CD86 in THP-1 Monocyte-Derived Macrophages

MiR-155 Acts As an Inhibitory Factor in Atherosclerosis-Associated Arterial Pathogenesis by Down-Regulating NoxA1 Related Signaling Pathway in ApoE-/- Mouse.

Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient mice

Experimental Study of Effect of IFNα-2b on Atherosclerosis

Abstract 309: TLR4 Gene Silencing Attenuates Atherosclerosis Progression Via Inhibition of PI3-kinase/Akt/NF-κB Signaling Pathway in Apolipoprotein E Knockout Mice

TLR3 and TLR4 As Potential Clinically Biomarkers of Cardiovascular Risk in Coronary Artery Disease (CAD) Patients.

Inhibitory Effect of Interferon Α-2B on Atherosclerosis

TLRs Are Important Inflammatory Factors in Atherosclerosis and May Be a Therapeutic Target.

Toll-Like Receptor 3 in Cardiovascular Diseases

Role of CD4+IL-9+T cells in experimental atherosclerosis

IL-33 Suppresses the Progression of Atherosclerosis Via the ERK1/2-IRF1-VCAM-1 Pathway.

Dynamic Changes of Type Th22 Cell Immunological Response During Atherosclerosis Process in Experimental Mice

Relationship Between Toll-like Receptor 4 Protein and Atherosclerosis

Interleukin-27 Ameliorates Atherosclerosis in ApoE-/- Mice Through Regulatory T Cell Augmentation and Dendritic Cell Tolerance.

The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway

Increased Expression of T Cell Immunoglobulin- and Mucin Domain-Containing Molecule-3 on Natural Killer Cells in Atherogenesis.

Protective Role of C3aR (c3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice.

NLRP3 Inflammasome in Atherosclerosis: Putting Out the Fire of Inflammation

Role of Toll-like Receptor9 in Progression of Atherosclerosis:Recent Advances